Merck Reports the Launch of Merck Digital Sciences Studio to Support Early-Stage Biomedical Startups
- Merck & the New Jersey Innovation Institute jointly developed MDSS to support startup technologies for drug discovery & development with investments from the Merck Global Health Innovation Fund, Northpond Ventures & McKesson Ventures. Microsoft will provide technical support to these startups
- MDSS will invest in the biomedical startups & will provide access to powerful Azure Cloud computing along with opportunities to pilot their technologies in collaboration with discovery & clinical scientists at Merck
- The application for 12 spots for the first MDSS group was initiated by Merck, startups focusing on AI & ML applications will be a priority. The program also plans to include 6 startups at each of its locations (Newark, NJ & Cambridge, MA)
Ref: Businesswire | Image: Merck
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at [email protected].